Estimating potential cost savings associated with managing COPD according to GOLD 2017 recommendations in UK primary care: a CPRD study

A. Mathioudakis (Manchester, United Kingdom), J. Vestbo (Manchester, United Kingdom), A. Gayle (Bracknell, United Kingdom), S. Dickinson (Bracknell, United Kingdom), K. Morris (Bracknell, United Kingdom), S. Webster (Bracknell, United Kingdom), C. Poole (Bracknell, United Kingdom)

Source: International Congress 2018 – COPD management
Session: COPD management
Session type: Thematic Poster
Number: 4377
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Mathioudakis (Manchester, United Kingdom), J. Vestbo (Manchester, United Kingdom), A. Gayle (Bracknell, United Kingdom), S. Dickinson (Bracknell, United Kingdom), K. Morris (Bracknell, United Kingdom), S. Webster (Bracknell, United Kingdom), C. Poole (Bracknell, United Kingdom). Estimating potential cost savings associated with managing COPD according to GOLD 2017 recommendations in UK primary care: a CPRD study. 4377

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The GOLD COPD categories are inaccurate in predicting future risk in a UK primary care dataset and the 2014 changes to cut-off values have not helped
Source: International Congress 2014 – Respiratory disease management in primary care
Year: 2014


Relating the new COPD GOLD strategy to quality-of-life and costs in a primary care population
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013

Management of COPD in primary care: an audit of NICE guidance and cost effectiveness
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017


Cost and effectiveness of integrated care intervention on the patients with COPD
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013


COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013

Cost and effectiveness of 2 years integrated care intervention in COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015


Inappropriate prescriptions following initial COPD diagnosis
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013


Mapping of COPD guideline adherence in primary care: An observational study in Belgium and Luxembourg
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013


Implementing local guidelines: the potential for cost savings and improvement of patient care
Source: Eur Respir J 2006; 28: Suppl. 50, 319s
Year: 2006

The economic burden of COPD in a Swedish cohort: The ARCTIC study
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016

Prevalence of comorbidities in established and newly treated patients with COPD according to GOLD 2017 in a UK primary care population
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018




Health care utilization and costs of asthma and COPD in the Netherlands
Source: Eur Respir J 2005; 26: Suppl. 49, 383s
Year: 2005

Predictive value of annual costs on 3-year mortality in COPD
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015


The primary care routine data registry BeoNet: First pilot phase results for COPD research
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015

Hospital resource use for COPD patients varies by both clinical commissioning group and primary care practices across nine CCGs in the United Kingdom
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015


Healthcare costs associated with short-acting ß2-agonist use in asthma: an observational UK study from the SABINA global programme
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021


Audit of quality of reviews of COPD patients in a UK primary care practice
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013


Protocol to identify potential severe asthma in UK primary care
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019


The distribution of COPD in UK general practice using the 2017 GOLD classification
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017


Health care costs associated with acute asthma: a economic analysis
Source: Eur Respir J 2002; 20: Suppl. 38, 42s
Year: 2002